APA (7th ed.) Citation

ML, Z., & K, L. (2025). AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG. Gene therapy, 32(3), 246. https://doi.org/10.1038/s41434-025-00525-w

Chicago Style (17th ed.) Citation

ML, Zhong, and Lai K. "AAV-based Gene Replacement Therapy Prevents and Halts Manifestation of Abnormal Neurological Phenotypes in a Novel Mouse Model of PMM2-CDG." Gene Therapy 32, no. 3 (2025): 246. https://doi.org/10.1038/s41434-025-00525-w.

MLA (9th ed.) Citation

ML, Zhong, and Lai K. "AAV-based Gene Replacement Therapy Prevents and Halts Manifestation of Abnormal Neurological Phenotypes in a Novel Mouse Model of PMM2-CDG." Gene Therapy, vol. 32, no. 3, 2025, p. 246, https://doi.org/10.1038/s41434-025-00525-w.